Veterinary Medicines

NEKRO-VEYXYM, injekcinė suspensija

Authorised
  • Papain
  • Trypsin
  • Chymotrypsin
Download as PDF

Product identification

Medicine name:
NEKRO-VEYXYM, injekcinė suspensija
Active substance:
  • Papain
  • Trypsin
  • Chymotrypsin
Target species:
  • Cattle
  • Cattle (calf)
  • Pig
  • Pig (piglet)
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Papain
    15.00
    FIP
    /
    1.00
    millilitre(s)
  • Trypsin
    120.00
    FIP
    /
    1.00
    millilitre(s)
  • Chymotrypsin
    1200.00
    FIP
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal, milk
        0
        day
    • Cattle (calf)
      • Meat
        0
        day
    • Pig
      • Meat
        0
        day
    • Pig (piglet)
      • Meat
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM09AB52
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/02/1421/001-002
Date of authorisation status change:

Documents

RV1421.pdf

Lithuanian (PDF)
Published on: 21/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."